IDEX Corporation (NYSE:IEX - Get Free Report) has received an average rating of "Moderate Buy" from the eight brokerages that are presently covering the stock, MarketBeat reports. Two analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $212.50.
IEX has been the topic of a number of analyst reports. Mizuho set a $185.00 price target on IDEX in a research report on Friday, May 16th. Citigroup cut their price objective on IDEX from $264.00 to $201.00 and set a "buy" rating on the stock in a research note on Monday, April 14th. Robert W. Baird set a $215.00 target price on shares of IDEX in a research report on Friday, May 2nd. Royal Bank Of Canada boosted their price target on shares of IDEX from $206.00 to $208.00 and gave the stock an "outperform" rating in a research report on Friday, May 2nd. Finally, DA Davidson decreased their price objective on shares of IDEX from $225.00 to $215.00 and set a "neutral" rating for the company in a research report on Wednesday, February 19th.
Read Our Latest Stock Analysis on IEX
IDEX Trading Down 0.7%
Shares of IDEX stock traded down $1.16 on Wednesday, hitting $174.83. The stock had a trading volume of 888,840 shares, compared to its average volume of 587,418. The stock has a 50 day moving average of $178.31 and a 200 day moving average of $193.52. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.99 and a current ratio of 2.79. IDEX has a twelve month low of $153.36 and a twelve month high of $238.22. The firm has a market capitalization of $13.21 billion, a P/E ratio of 27.71, a PEG ratio of 1.79 and a beta of 1.06.
IDEX (NYSE:IEX - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The industrial products company reported $1.75 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.64 by $0.11. IDEX had a net margin of 14.60% and a return on equity of 15.51%. The firm had revenue of $814.30 million during the quarter, compared to the consensus estimate of $807.25 million. During the same quarter last year, the firm earned $1.88 earnings per share. The company's revenue for the quarter was up 1.7% on a year-over-year basis. Sell-side analysts expect that IDEX will post 8.26 earnings per share for the current fiscal year.
IDEX Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, July 11th will be given a dividend of $0.71 per share. This represents a $2.84 dividend on an annualized basis and a dividend yield of 1.62%. IDEX's payout ratio is presently 45.01%.
Insiders Place Their Bets
In other news, CFO Akhil Mahendra sold 250 shares of the stock in a transaction dated Thursday, June 5th. The shares were sold at an average price of $180.89, for a total transaction of $45,222.50. Following the transaction, the chief financial officer now owns 5,035 shares of the company's stock, valued at $910,781.15. This represents a 4.73% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.50% of the company's stock.
Institutional Inflows and Outflows
A number of large investors have recently made changes to their positions in the business. Empowered Funds LLC lifted its position in IDEX by 22.9% in the 4th quarter. Empowered Funds LLC now owns 1,592 shares of the industrial products company's stock valued at $333,000 after acquiring an additional 297 shares in the last quarter. Asset Management One Co. Ltd. raised its stake in shares of IDEX by 4.2% in the fourth quarter. Asset Management One Co. Ltd. now owns 30,250 shares of the industrial products company's stock worth $6,386,000 after purchasing an additional 1,209 shares during the last quarter. Handelsbanken Fonder AB lifted its holdings in shares of IDEX by 6.1% in the fourth quarter. Handelsbanken Fonder AB now owns 20,800 shares of the industrial products company's stock valued at $4,353,000 after purchasing an additional 1,200 shares in the last quarter. Boston Financial Mangement LLC purchased a new position in shares of IDEX during the fourth quarter valued at approximately $226,000. Finally, Allianz Asset Management GmbH grew its holdings in IDEX by 133.2% during the fourth quarter. Allianz Asset Management GmbH now owns 406,637 shares of the industrial products company's stock worth $85,105,000 after buying an additional 232,255 shares in the last quarter. 97.96% of the stock is owned by institutional investors.
IDEX Company Profile
(
Get Free ReportIDEX Corporation, together with its subsidiaries, provides applied solutions worldwide. The company operates through three segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT segment designs, produces, and distributes positive displacement pumps, valves, small volume provers, flow meters, injectors, and other fluid-handling pump modules and systems, as well as flow monitoring and other services for the food, chemical, general industrial, water and wastewater, agricultural, and energy industries.
Recommended Stories

Before you consider IDEX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IDEX wasn't on the list.
While IDEX currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.